DaVita Responds to Proposition 23 in California
DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot...
DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. During the quarter, notwithstanding the challenges of responding to COVID-19, the...
DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, at 5:00 p.m. Eastern Time. The company...
DaVita joins Dialysis Patient Citizens in supporting BETTER Kidney Care Act Bipartisan, bicameral legislation would improve quality of life for patients with kidney disease DaVita joins...